Navigation Links
Team solves birth and migration mysteries of cortex's powerful inhibitors, 'chandelier' cells
Date:11/22/2012

'

After three years of painstaking work that has involved using new technologies to identify and trace neural cell progenitors in ways not previously possible, and to track them as they migrate to positions in the maturing cortex, Huang and colleagues, including Dr. Hiroki Taniguchi now at the Max Planck Florida Institute, have demonstrated that chandelier cells are born in a previously unrecognized portion of the embryonic brain, which they have named the VGZ (ventral germinal zone).

Huang, who has been on a decade-long quest to develop means of learning much more about the cortex's inhibitory cells (sometimes called "interneurons"), points out that while they are far less numerous than the excitatory pyramidal cells all around them, cells including chandelier cells that inhibit or modulate excitatory-cell messages play an indispensable role in balancing message flow and ultimately in determining the functional organization of excitatory neurons into meaningful groups.

This is all the more intriguing in the case of chandelier cells, Huang explains, because of their distinctive anatomy: one cell that can regulate the messages of 500 others in its vicinity is one that we need to know about if we want to understand how brain circuits work. Unlike other inhibitory cells, chandelier cells are known to connect with excitatory cells at one particular anatomical location, of great significance: a place called the axon initial segment (AIS) the spot where a "broadcasting" pyramidal cell generates its transmittable message. To be able to interdict 500 "broadcasters" at this point renders a single chandelier cell a very important player in message propagation and coordination within its locality.

Because of the strategic importance of such cells throughout the cortex, it has been a source of frustration to neuroscientists that they (and other inhibitory cells) have been difficult to classify. Huang has pursued a strategy of fol
'/>"/>

Contact: Peter Tarr
tarr123@gmail.com
917-435-5068
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. After 121 years, identification of grave robber fossil solves a paleontological enigma
2. George Washington University Computational Biology Director solves 200-year-old oceanic mystery
3. New release of Web-based resource resolves confusion over plant names
4. Study resolves debate on human cell shut-down process
5. International team discovers likely basis of birth defect causing premature skull closure in infants
6. US preterm birth rate shows 5-year improvement
7. Finding triggers of birth defects in an embryo heart
8. Researchers identify genetic basis of cardiac, craniofacial birth defects
9. Obese moms give birth to heart healthier kids following bariatric surgery
10. Imaging study sheds new light on alcohol-related birth defects
11. Massachusetts Eye and Ear researchers discover elusive gene that causes a form of blindness from birth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of ... report to their offering. One ... adoption of multimodal biometric systems. Multimodal biometric systems ... for verification and identification purposes. This helps to ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a ... it is seeing a staggering demand from its licensees ... the Company revealed, is not solely coming from fitness ... as well. "A wearable is only as ... result, accuracy is the ultimate driver in long-term mass ...
(Date:12/10/2014)...     Jifflenow ...   Jifflenow, a leading provider ... business-to-business (B2B) events, today announced a partnership with ... communication (NFC), Bluetooth low energy (BLE), and cloud-based ... Jifflenow will integrate its meeting scheduling ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
... Imagine that the players on your favourite football team ... helmets or pads. Left defenseless, they would become easy prey ... have left small water organisms vulnerable to their predators, which ... study. "At low calcium levels the organisms grow slower ...
... release as much as 1 billion tons of carbon emissions ... reported, according to a new Duke led study. Published ... provides the most comprehensive estimate of global carbon emissions from ... 1.2 billion tons. It suggests there is a high value ...
... study led by MIT neuroscientists has found that brain ... predict whether they will benefit from cognitive behavioral therapy. ... behavioral therapy or medications. However, it is currently impossible ... particular patient. The team of researchers from MIT, Boston ...
Cached Biology News:Changes in water chemistry leave lake critters defenseless 2Destroyed coastal habitats produce significant greenhouse gas 2Predicting how patients respond to therapy 2Predicting how patients respond to therapy 3
(Date:12/19/2014)... LayerBio is an MIT spin-off developing ... The National Eye Institute (NEI) at the National Institutes ... SBIR grant to develop a drug-eluting intraocular lens (IOL) ... cause of vision loss in people over age 40 ... Dr. Ken Mandell, LayerBio’s Founder and CEO, "There is ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... to the rising ageing population and technological innovations ... and nutraceutical industries are catalysing the growth of ... @ http://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html , Scope of Report ... as well as new entrants/smaller firms to gauge ...
(Date:12/19/2014)... 18, 2014 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... of chronic pain, announced the results of its annual ... was a transformational year in Relmada,s history and it ... company," said Sergio Traversa , chief executive officer ... on key financial, human resource and clinical development objectives ...
(Date:12/17/2014)... December 17, 2014 Ipsen Biopharmaceuticals, ... IPN; ADR: IPSEY), today announced that ... as Somatuline®) was approved by the U.S. Food ... gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with ... metastatic disease to improve progression-free survival (PFS). , ...
Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
... N.J., Jan. 11 A new blood test that identifies ... in the U.S. through Quest Diagnostics Incorporated (NYSE: ... is designed to aid the detection of colorectal cancer, the ... test is based on DNA methylation of the Septin9 gene, ...
... , , , , ... Cooperation With Diabetes Leader Novo Nordisk, - Important ... The Gerresheimer Group has set up a new ... commence operations early in,2010. On the basis of a long-term cooperation ...
... New chapter ... , ... -- The Society for Clinical Data Management recently published Edit Check Design Principles, a collection ... and data quality., , ,The chapter is a new addition to SCDM’s Good Clinical ...
Cached Biology Technology:Quest Diagnostics Introduces Molecular Blood Test for Aiding Colorectal Cancer Detection 2Quest Diagnostics Introduces Molecular Blood Test for Aiding Colorectal Cancer Detection 3Gerresheimer Sets up New Production Facility for Insulin Pen Systems in Brazil 2SCDM Releases Best Practices for Automated Data Cleaning 2
... flexible quadrupole MS detector optimized for HPLC ... and 2-D LC, as well as capillary ... drying gas system to create a finer ... low-to-medium polarity compounds, while providing for high ...
... is the ideal CO2 incubator for cell ... or embryos at or near body temperature. ... everything needed to protect and grow your ... stable incubation conditions ensure optimum culture growth. ...
... single-stranded DNA and RNA endonucleolytically to ... (DNA:DNA, DNA:RNA or RNA:RNA) are resistant ... concentrations of enzyme (1). The enzyme ... from double-stranded DNA (2), for selective ...
... DNA Ligation Kit enables ligation ... fragments in just 5 min ... on the DNA concentration, either ... concatemeric (high DNA concentration) ligation ...
Biology Products: